One of the world's largest private AI companies - BenevolentAI, that develops and applies AI for scientific innovation, has hired Dr Nathan Brown, as its new Head of Cheminformatics.
Nathan Brown has extensive experience as a software designer and has developed many novel algorithms to maximise the impact of the experimental data generated in medicinal chemistry and cancer biology. Nathan is a recent recipient of the Corwin Hansch Award for contributions to computational chemistry.
Nathan joined the Institute of Cancer Research (“ICR”), London in 2007 where he founded and led the new In Silico Medicinal Chemistry Group which focussed on medicinal chemistry research towards novel cancer treatments. Nathan holds a degree in computing from Robert Gordon University, Aberdeen and conducted his doctoral research in the field of Cheminformatics at the University of Sheffield.
Following his PhD Nathan was awarded a Marie Curie Fellowship for two years working with Avantium in Amsterdam and subsequently one of the first to be awarded a prestigious Presidential Research Fellowship for three years, by Professor Mark Fishman, Global Head of Research at the Novartis Institutes for BioMedical Research.
Jackie Hunter, CEO of BenevolentBio, the bioscience subsidiary of BenevolentAI, commented “Nathan Brown is a recognised leader in the field of cheminformatics, molecular informatics and computational chemistry. He has done exceptional work in the development of innovative anti-cancer therapies in an academic setting and his work is respected and well published. We are delighted to have Nathan on board.”